Crossmark

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies

Crossref DOI link: https://doi.org/10.1186/s40900-018-0108-0

Published Online: 2018-07-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Batten, Leona M.

Bhattacharya, Indrani Subarna

Moretti, Laura

Haviland, Joanne S.

Emson, Marie A.

Miller, Sarah E.

Jefford, Monica

MacKenzie, Mairead

Wilcox, Maggie

Hyslop, Marie

Todd, Rachel

Snowdon, Claire F.

Bliss, Judith M.
Funding

Funding for this research was provided by:

Cancer Research UK (C1491/A15955)

Cancer Research UK (C1491/A8895)
License Information

Text and Data Mining valid from 2018-07-16
More Information

Article History

Received: 9 June 2017

Accepted: 3 July 2018

First Online: 16 July 2018

Ethics approval and consent to participate

: All clinical trials mentioned by name in this paper had full ethical review and approval, all patients that took part with the studies consented to do so. Further details: IMPACT was approved first by a national multicenter research ethical committee and subsequently by individual local research ethics committees; POETIC – South East Research Ethics Committee, 08/H1102/37; PALLET – London Fulham Research Ethics Committee, 14/LO/1291.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.